Endoluxe
Private Company
Funding information not available
Overview
Endoluxe is a private, commercial-stage medical device company pioneering a wireless, integrated endoscopy system. Founded in 2018 by physicians, its platform aims to modernize endoscopic procedures by eliminating cables, improving portability, and integrating data analytics. The company has initiated commercial activities with its Endoluxe Vision system in urology and ENT and is developing a pipeline of AI-driven surgical intelligence tools, positioning it in the growing digital surgery market.
Technology Platform
Wireless, all-in-one endoscopic visualization hardware integrated with a cloud-based digital health platform for data management and an in-development surgical intelligence engine using computer vision.
Opportunities
Risk Factors
Competitive Landscape
Endoluxe competes with large, established medical device companies like Karl Storz, Olympus, and Stryker that dominate the traditional endoscopy tower market. It also faces emerging competition from other digital surgery and AI startups. Its differentiation is the fully wireless, all-in-one form factor and its integrated platform approach combining hardware, cloud software, and AI.